KẾT QUẢ ĐIỀU TRỊ RỐI LOẠN GIẤC NGỦ Ở NGƯỜI BỆNH NỘI TRÚ GIAI ĐOẠN TRẦM CẢM TẠI VIỆN SỨC KHỎE TÂM THẦN

Abstract

Objectives: To describe the results of treatment of sleep disturbance in patients with depressive inpatient treatment at the National Institute of Mental Health. Subjects and methods: A comparative cross-sectional description before and after 14 days of treatment in depressive episode patients treated inpatient at National Institute of Mental Health - Bach Mai Hospital from September 2021 to May 2022. Results: Female patients in depressive episode is 1.6 times higher than male patients, the common age group was from 50 - 59 years old (30.9%), the onset time to clinical treatment time is common from 3 to 6 months (45.5%) with the most common severity o hospitalization being a major depressive episode without psychotic symptoms (52.7%). Most of the patients were treated with a combination of antidepressants, antipsychotics and tranquilizers (72.73%), after 14 days of treatment, there was a decrease in the time to fall asleep, the number of times waking up in the middle of the night, wake up earlier than usual; increase in sleep time per night and increase in sleep efficiency statistically significant with α = 0.01. The improvement of the disease status is also shown by the PSQI and HAMD scores; The average HAMD score decreased from 22.96 to 9.15 points, the PSQI scale decreased from 16.07 to 11.65 points. Conclusion: Sleep disturbance in the depressive episode is a symptom that persists longer than other symptoms of depression, the combination of treatment measures increases the effectiveness of treatment, the occurrence of other symptoms is less, unwanted effects during treatment.